LYNZI MARIE MORGAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PRYOR, OK NPI 1700545662

General Payments — all program years on this page

$892.96

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $355.80 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $355.8021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $173.6310
2023 $363.5321
2024 $355.8021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086273534 Bayer Healthcare Pharmaceuticals Inc. $16.05 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086325316 Bayer Healthcare Pharmaceuticals Inc. $14.28 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086339475 Bayer Healthcare Pharmaceuticals Inc. $14.08 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100486945 Novo Nordisk Inc $19.05 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100625892 Novo Nordisk Inc $19.13 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104777522 AstraZeneca Pharmaceuticals LP $13.69 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105528880 AstraZeneca Pharmaceuticals LP $14.93 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107692144 ABBVIE INC. $29.11 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116283041 GlaxoSmithKline, LLC. $21.71 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117332592 Amgen Inc. $14.92 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119143417 Otsuka America Pharmaceutical, Inc. $17.09 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131069000 PFIZER INC. $13.31 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131151118 PFIZER INC. $14.36 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131151122 PFIZER INC. $13.25 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131765598 PFIZER INC. $18.07 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135770180 Lilly USA, LLC $14.16 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135770182 Lilly USA, LLC $14.01 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135806839 Lilly USA, LLC $28.92 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139509965 Astellas Pharma US Inc $14.01 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146064031 Lundbeck LLC $16.78 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147899398 Supernus Pharmaceuticals, Inc. $14.89 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.